首页|右美托咪定预防扁桃体腺样体切除术患儿全麻气管拔管后呼吸异常的临床效果观察

右美托咪定预防扁桃体腺样体切除术患儿全麻气管拔管后呼吸异常的临床效果观察

扫码查看
目的 观察右美托咪定(DEX)预防扁桃体腺样体切除术患儿全身麻醉(全麻)气管拔管后呼吸异常的临床效果.方法 120 例行扁桃体腺样体切除术的患儿,应用随机数字表法分为研究组和对照组,每组 60 例.研究组按 0.5 μg/kg计算量泵注DEX,对照组泵注相同计算量 0.9%氯化钠.记录并比较两组患儿手术时间;术后拔管时间;麻醉后监测治疗室(PACU)停留时间;不同时间[入室(T1)、插管即刻(T2)、手术开始(T3)、拔管即刻(T4)、送出PACU时(T5)]的心率(HR)、平均动脉压(MAP);呼吸异常、血氧饱和度(SpO2)进行性下降、负压性肺水肿发生情况.结果 两组患儿手术时间、术后拔管时间、PACU停留时间比较,差异无统计学意义(P>0.05).研究组患儿T2、T3、T4、T5 时的HR分别为(96.6±4.3)、(95.4±7.6)、(90.6±3.5)、(92.3±5.4)次/min,均低于T1 的(104.3±3.6)次/min,MAP分别为(75.4±4.8)、(73.3±4.4)、(71.5±3.4)、(72.2±3.6)mm Hg(1 mm Hg=0.133 kPa),均低于T1 的(81.5±3.3)mm Hg;但对照组患儿T2、T3、T4、T5 时的HR分别为(110.2±5.6)、(123.6±6.4)、(115.7±4.5)、(108.3±6.8)次/min,均高于T1 的(105.3±5.1)次/min,MAP分别为(85.3±6.7)、(89.3±4.3)、(84.2±3.8)、(85.6±2.7)mm Hg,均高于T1 的(80.2±5.5)mm Hg;研究组患儿T2、T3、T4、T5 时的HR、MAP水平均低于对照组(P<0.05).研究组呼吸异常、SpO2 进行性下降、负压性肺水肿发生率分别为 6.7%、0、0,均低于对照组的 23.3%、6.7%、6.7%,差异有统计学意义(P<0.05).结论 小儿扁桃体腺样体切除术后拔管呼吸异常发生率高,通过小剂量DEX泵注有助于维持患儿血流动力学的稳定,能够明显降低呼吸异常的发生率,且对患儿的恢复时间无明显影响,值得推广.
Clinical observation of dexmedetomidine in preventing abnormal respiration after tracheal extubation under general anesthesia in children undergoing tonsillectomy and adenoidectomy
Objective To observe the clinical effect of dexmedetomidine(DEX)in preventing abnormal respiration after tracheal extubation under general anesthesia in children undergoing tonsillectomy and adenoidectomy.Methods 120 children underwent tonsillectomy and adenoidectomy were divided into a study group and a control group by random number table method,with 60 cases in each group.The study group was infused with DEX at a calculated amount of 0.5 μg/kg,and the control group was infused with the same calculated amount of 0.9%sodium chloride.Record and comparison were made on operation time,postoperative extubation time,post-anesthesia care unit(PACU)length of stay,heart rate(HR)and mean arterial pressure(MAP)at different time points[before anesthesia(T1),immediately after intubation(T2),beginning of surgery(T3),immediately after extubation(T4),and leaving PACU(T5)],abnormal respiration,progressive in blood oxygen saturation(SpO2)decline,negative pressure pulmonary edema between the two groups.Results There was no statistically significant difference in operation time,extubation time and PACU length of stay between the two groups(P>0.05).In the study group,the HR at T2,T3,T4 and T5 were(96.6±4.3),(95.4±7.6),(90.6±3.5)and(92.3±5.4)beats/min,which were lower than(104.3±3.6)beats/min at T1;and the MAP were(75.4±4.8),(73.3±4.4),(71.5±3.4)and(72.2±3.6)mm Hg(1 mm Hg= 0.133 kPa),which were lower than(81.5±3.3)mm Hg at T1.In the control group,the HR at T2,T3,T4 and T5 were(110.2±5.6),(123.6±6.4),(115.7±4.5)and(108.3±6.8)beats/min,which were higher than(105.3±5.1)beats/min at T1;and the MAP were(85.3±6.7),(89.3±4.3),(84.2±3.8)and(85.6±2.7)mm Hg,which were higher than(80.2±5.5)mm Hg at T1.The levels of HR and MAP at T2,T3,T4 and T5 in the study group were lower than those in the control group(P<0.05).The incidence of abnormal respiration,progressive SpO2 decline and negative pressure pulmonary edema in the study group were 6.7%,0 and 0,which were lower than 23.3%,6.7%and 6.7%in the study group,with statistical significance(P<0.05).Conclusion The incidence of abnormal respiration after tracheal extubation in children undergoing tonsillectomy and adenoidectomy is high.Low-dose DEX infusion can help to maintain the stability of hemodynamics in children,and can significantly reduce the incidence of abnormal respiration,and has no significant effect on the recovery time of children,which is worth popularizing.

DexmedetomidineTonsillectomy and adenoidectomyAbnormal respiration

袁亚庆、董芳芳、陆小丽

展开 >

213002 南通大学附属常州儿童医院麻醉科

右美托咪定 扁桃体腺样体切除术 呼吸异常

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(3)
  • 15